September 30, 2025 · Form 4 insider transaction
Apeiron Investment Group Ltd. sold 147,950 shares of ATAI LIFE SCIENCES NV, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
The conversion price for the Convertible Notes is EUR 17.00 per note.; The Convertible Notes were acquired in exchange for convertible notes issued by ATAI Life Sciences AG with substantially similar terms and economics.